Results of the CCK-8 assay (Figures 2(b) and 2(c)) and EdU assay (Figures 2(d) and 2(e)) demonstrated that CCDC183-AS1 knockdown retarded BC cell proliferation. Here, CCDC183 is linked to breast cancer.